Breaking News

Fungal Treatment

March 9, 2006

Patent No. US 6,986,896 B2: Bradley Pharmaceuticals, Inc., Fairfield, NJ, patented a method for treating fungal skin conditions. The fungal condition is Tinea pedis, a condition caused by a dermatophyte, a trichophyton, an epidermophyton and Candida Albicans. The product consists of urea as the sole active ingredient and a dermatologically acceptable excipient.
blog comments powered by Disqus